How does microbial molecular pathology differ from traditional clinical microbiology?

Traditional microbiology relies on culture, microscopy, and phenotypic tests, whereas molecular pathology adds nucleic acid- and sequence-based methods that can identify and characterise organisms, including those that grow poorly or not at all in culture.

Do molecular methods replace culture?

Not entirely; molecular and culture-based methods are often complementary. Culture remains important for phenotypic susceptibility testing and recovery of isolates, while molecular methods add speed, sequence-level identification, and detection of resistance determinants.

Microbial Molecular Pathology

Microbial molecular pathology is the application of nucleic acid- and protein-based laboratory methods to detect, identify, characterise, and track infectious agents — bacteria, viruses, fungi, and parasites — and the genetic determinants that govern their virulence and resistance. It sits at the intersection of clinical microbiology and molecular diagnostics, complementing culture and microscopy with sequence-level information.

Finn tema med PaperMindSnartFind papers & topics

Tools & resources

Last ned lysbilder

Learn & explore

VideoSnart

Definition

Microbial molecular pathology is the branch of laboratory medicine that uses molecular techniques — nucleic acid amplification, sequencing, hybridisation, and mass spectrometry-based profiling — to identify pathogens, characterise their genomes, and infer epidemiological and resistance information.

Scope

This area orients the reader to the molecular approaches used in diagnostic microbiology: amplification and sequencing of conserved marker genes for organism identification, genotyping and phylogenetic analysis for outbreak tracing and evolution, detection of resistance genes, molecular diagnosis of fungal and parasitic disease, and culture-independent metagenomic and whole-genome strategies. It frames these as laboratory and reference topics rather than as bedside management instructions.

Sub-topics

Core questions

Which organism is present, and to what species or strain can it be resolved by molecular markers?
How are related isolates connected in transmission, and what does phylogeny reveal about their evolution?
Which resistance and virulence determinants are encoded, and how mobile are they?
When should culture-independent (metagenomic or whole-genome) methods be preferred over targeted assays?

Key concepts

Conserved marker genes (16S rRNA, ITS) as identification targets
Nucleic acid amplification testing (PCR and variants)
Genotyping and molecular strain typing
Phylogenetic inference and molecular epidemiology
Genotypic resistance detection
Culture-independent diagnostics
Whole-genome and metagenomic sequencing

Mechanisms

Molecular microbiology methods exploit sequence differences between organisms. Conserved-but-variable marker genes — the bacterial 16S rRNA gene and the fungal internal transcribed spacer (ITS) region — can be amplified and sequenced to place an isolate taxonomically (Patel, 2001). Strain-level discrimination uses banding or sequence-based typing to judge whether isolates are related (Tenover, 1995). Comparing sequences across samples allows phylogenetic reconstruction of how pathogens evolve and spread (Pybus & Rambaut, 2009). Culture-independent metagenomic sequencing reads nucleic acids directly from clinical material, in principle detecting any organism present without prior knowledge of what to look for (Miller & Chiu, 2020).

Clinical relevance

Molecular methods describe how modern laboratories identify pathogens, detect resistance determinants, and reconstruct transmission, which underpins diagnostic reporting, infection-prevention surveillance, and antimicrobial stewardship at a system level. This entry explains how such evidence is generated and is not a guide to diagnosing or treating any individual patient.

Evidence & guidelines

The methods summarised here draw on diagnostic and methodological literature in clinical microbiology, including standardised criteria for interpreting strain-typing patterns (Tenover, 1995) and reviews weighing the clinical role of metagenomic sequencing (Miller & Chiu, 2020). Specific assay performance and reporting standards are set by professional and regulatory bodies and are not reproduced here.

History

Molecular microbiology grew from the spread of PCR and DNA sequencing in the late twentieth century, which made conserved-gene identification (Patel, 2001) and reproducible molecular strain typing (Tenover, 1995) routine. The maturation of high-throughput sequencing then extended the field to whole-genome and metagenomic approaches that read pathogen genomes directly from clinical samples (Miller & Chiu, 2020).

Seminal works

patel-2001
tenover-1995
pybus-2009

Frequently asked questions

How does microbial molecular pathology differ from traditional clinical microbiology?: Traditional microbiology relies on culture, microscopy, and phenotypic tests, whereas molecular pathology adds nucleic acid- and sequence-based methods that can identify and characterise organisms, including those that grow poorly or not at all in culture.
Do molecular methods replace culture?: Not entirely; molecular and culture-based methods are often complementary. Culture remains important for phenotypic susceptibility testing and recovery of isolates, while molecular methods add speed, sequence-level identification, and detection of resistance determinants.